This drug class, called GLP-1 agonists, incorporates semaglutide—accepted as Ozempic for style 2 diabetic issues and Wegovy for obesity—and tirzepatide—authorised as Mounjaro for diabetic issues and Zepbound https://tiffanyvzsm267367.popup-blog.com/profile